Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease

World Journal of Gastroenterology

Volumn 20, Issue 25, 2014, Pages 8055-8060

  Nan, Yue Min ^a   Wang, Rong Qi ^a   Fu, Na ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Alcoholic liver disease; Fibrosis; Inflammation; Oxidative stress; Peroxisome proliferator activated receptor

Indexed keywords

ACYL COENZYME A OXIDASE; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CATALASE; CYCLOOXYGENASE 2; CYTOCHROME P450 2E1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; FIBRIC ACID DERIVATIVE; GELATINASE A; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHTHALIC ACID ESTER; PIRINIXIC ACID; RETINOIC ACID RECEPTOR ALPHA; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; ACETALDEHYDE; CYTOCHROME P450; GELATINASE B; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID;

ALCOHOL LIVER DISEASE; ARTICLE; CELL ACTIVATION; DRUG TARGETING; FATTY ACID OXIDATION; FIBROGENESIS; GENE EXPRESSION; HUMAN; INFLAMMATION; LIPID METABOLISM; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STELLATE CELL; DNA BINDING; LIPID OXIDATION; LIPID PEROXIDATION; REGULATORY MECHANISM; REVIEW; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG DESIGN; DRUG EFFECTS; LIVER; LIVER DISEASES, ALCOHOLIC; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DRUG DESIGN; HUMANS; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; LIVER DISEASES, ALCOHOLIC; MOLECULAR TARGETED THERAPY; OXIDATIVE STRESS; PPAR ALPHA; SIGNAL TRANSDUCTION;

EID: 84903985918     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i25.8055     Document Type: Article

References (50)

1. Warren KR, Murray MM. Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism. J Gastroenterol Hepatol 2013; 28 Suppl 1: 4-6 [PMID: 23855288 DOI: 10.1111/jgh.12246]
2. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010; 105: 14-32; quiz 33 [PMID: 19904248 DOI: 10.1038/ajg.2009.593]
3. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010; 29: 437-445 [PMID: 20636661 DOI: 10.1111/ j.1465-3362.2009.00153.x]
4. Sid B, Verrax J, Calderon PB. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic Res 2013; 47: 894-904 [PMID: 23800214 DOI: 10.3109/10715762]
5. Bugge A, Mandrup S. Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation. PPAR Res 2010; 2010: pii: 169506 [PMID: 20862367 DOI: 10.1155/2010/169506]
6. Hardwick JP, Chiang JY. PPARs, RXRs, and Drug-Metabolizing Enzymes. PPAR Res 2009; 2009: 589626 [PMID: 20369070 DOI: 10.1155/2009/589626]
7. Yoon M. PPARα in Obesity: Sex Difference and Estrogen Involvement. PPAR Res 2010; 2010: pii: 584296 [PMID: 20871824 DOI: 10.1155/2010/584296]
8. Kong L, Ren W, Li W, Zhao S, Mi H, Wang R, Zhang Y, Wu W, Nan Y, Yu J. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice. Lipids Health Dis 2011; 10: 246 [PMID: 22208561 DOI: 10.1186/1476-511X-10-246]
9. Haseba T, Ohno Y. A new view of alcohol metabolism and alcoholism--role of the high-Km Class III alcohol dehydrogenase (ADH3). Int J Environ Res Public Health 2010; 7: 1076-1092 [PMID: 20617019 DOI: 10.3390/ijerph7031076]
10. Ji C. Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol 2008; 23 Suppl 1: S16-S24 [PMID: 18336657 DOI: 10.1111/ j.1440-]
11. Rasineni K, Casey CA. Molecular mechanism of alcoholic fatty liver. Indian J Pharmacol 2012; 44: 299-303 [PMID: 22701235 DOI: 10.4103/0253-7613.96297]
12. Mello T, Polvani S, Galli A. Peroxisome proliferatoractivated receptor and retinoic x receptor in alcoholic liver disease. PPAR Res 2009; 2009: 748174 [PMID: 19756185 DOI: 10.1155/2009/748174]
13. Venkata NG, Aung CS, Cabot PJ, Monteith GR, Roberts-Thomson SJ. PPARalpha and PPARbeta are differentially affected by ethanol and the ethanol metabolite acetaldehyde in the MCF-7 breast cancer cell line. Toxicol Sci 2008; 102: 120-128 [PMID: 18003597]
14. Gyamfi MA, Kocsis MG, He L, Dai G, Mendy AJ, Wan YJ. The role of retinoid X receptor alpha in regulating alcohol metabolism. J Pharmacol Exp Ther 2006; 319: 360-368 [PMID: 16829625]
15. Alnouti Y, Klaassen CD. Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol Sci 2008; 101: 51-64 [PMID: 17998271]
16. Abdelmegeed MA, Moon KH, Hardwick JP, Gonzalez FJ, Song BJ. Role of peroxisome proliferator-activated receptoralpha in fasting-mediated oxidative stress. Free Radic Biol Med 2009; 47: 767-778 [PMID: 19539749 DOI: 10.1016/j.freera dbiomed.2009.06.017]
17. Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 2007; 20: 351-358 [PMID: 17671740]
18. Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ. Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology 2012; 56: 281-290 [PMID: 22318764 DOI: 10.1002/hep.25645]
19. Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem 2001; 276: 68-75 [PMID: 11022051]
20. Nanji AA, Dannenberg AJ, Jokelainen K, Bass NM. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. J Pharmacol Exp Ther 2004; 310: 417-424 [PMID: 15016835]
21. Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003; 278: 27997-28004 [PMID: 12791698]
22. Patsouris D, Reddy JK, Müller M, Kersten S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006; 147: 1508-1516 [PMID: 16357043]
23. Nan YM, Kong LB, Ren WG, Wang RQ, Du JH, Li WC, Zhao SX, Zhang YG, Wu WJ, Di HL, Li Y, Yu J. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice. Lipids Health Dis 2013; 12: 11 [PMID: 23388073 DOI: 10.1186/1476-511X-12-11]
24. Tsedensodnom O, Vacaru AM, Howarth DL, Yin C, Sadler KC. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Dis Model Mech 2013; 6: 1213-1226 [PMID: 23798569 DOI: 10.1242/dmm.012195]
25. Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med 2013; 65: 1238-1245 [PMID: 24064383 DOI: 10.1016/j.freeradbiomed.2013.09.009]
26. Kim T, Yang Q. Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system. World J Cardiol 2013; 5: 164-174 [PMID: 23802046 DOI: 10.4330/wjc. v5.i6.164]
27. Khoo NK, Hebbar S, Zhao W, Moore SA, Domann FE, Robbins ME. Differential activation of catalase expression and activity by PPAR agonists: Implications for astrocyte protection in anti-glioma therapy. Redox Biol 2013; 1: 70-79 [PMID: 24024139 DOI: 10.1016/j.redox.2012.12.006]
28. Liu X, Jang SS, An Z, Song H, Kim WD, Yu JR, Park WY. Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells. Radiat Oncol J 2012; 30: 88-95 [PMID: 22984687 DOI: 10.3857/roj.2012.30.2.88]
29. Li JL, Wang QY, Luan HY, Kang ZC, Wang CB. Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha. J Biomed Sci 2012; 19: 32 [PMID: 22435679 DOI: 10.1186/1423-0127-19-32]
30. Wang RQ, Nan YM, Wu WJ, Kong LB, Han F, Zhao SX, Kong L, Yu J. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice. Lipids Health Dis 2011; 10: 31 [PMID: 21314960 DOI: 10.1186/1476-511X-10-31]
31. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 2004; 40: 972-980 [PMID: 15382117]
32. Huang YW, Yang SS, Kao JH. Pathogenesis and management of alcoholic liver cirrhosis: a review. Hepat Med 2011; 3: 1-11 [PMID: 24367215]
33. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16: 1321-1329 [PMID: 20238398 DOI: 10.3748/wjg.v16.i11.1321]
34. Peng JH, Cui T, Sun ZL, Huang F, Chen L, Xu L, Feng Q, Hu YY. Effects of Puerariae Radix Extract on Endotoxin Receptors and TNF-α Expression Induced by Gut-Derived Endotoxin in Chronic Alcoholic Liver Injury. Evid Based Complement Alternat Med 2012; 2012: 234987 [PMID: 23133491 DOI: 10.1155/2012/234987]
35. Lee JH, Banerjee A, Ueno Y, Ramaiah SK. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro. Toxicol Sci 2008; 106: 290-299 [PMID: 18703563 DOI: 10.1093/toxsci/ kfn165]
36. Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C. Pivotal role of TLR4 receptors in alcoholinduced neuroinflammation and brain damage. J Neurosci 2010; 30: 8285-8295 [PMID: 20554880 DOI: 10.1523/JNEUROSCI. 0976-10.2010]
37. Dominguez M, Miquel R, Colmenero J, Moreno M, García-Pagán JC, Bosch J, Arroyo V, Ginès P, Caballería J, Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009; 136: 1639-1650 [PMID: 19208360 DOI: 10.1053/j.gastro.2009.01.056]
38. Moriya T, Naito H, Ito Y, Nakajima T. "Hypothesis of seven balances": molecular mechanisms behind alcoholic liver diseases and association with PPARalpha. J Occup Health 2009; 51: 391-403 [PMID: 19706994]
39. Krönke G, Kadl A, Ikonomu E, Blüml S, Fürnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR, Leitinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2007; 27: 1276-1282 [PMID: 17413033]
40. Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009; 83: 519-548 [PMID: 19448996 DOI: 10.1007/s00204-009-0432-0]
41. Cubero FJ, Nieto N. Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Hepatology 2008; 48: 2027-2039 [PMID: 19003881 DOI: 10.1002/hep.22592]
42. Moschen AR, Gerner R, Schroll A, Fritz T, Kaser A, Tilg H. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis. Hepatology 2011; 54: 675-686 [PMID: 21567435 DOI: 10.1002/hep.24416]
43. Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res 2012; 347: 245-256 [PMID: 22006249 DOI: 10.1007/s00441-011-1246-y]
44. Tipoe GL, Liong EC, Casey CA, Donohue TM, Eagon PK, So H, Leung TM, Fogt F, Nanji AA. A voluntary oral ethanolfeeding rat model associated with necroinflammatory liver injury. Alcohol Clin Exp Res 2008; 32: 669-682 [PMID: 18341647 DOI: 10.1111/j.1530-0277.2008]
45. Mandal P, Park PH, McMullen MR, Pratt BT, Nagy LE. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 2010; 51: 1420-1429 [PMID: 20052772 DOI: 10.1002/hep.23427]
46. Zhou JY, Jiang ZA, Zhao CY, Zhen Z, Wang W, Nanji AA. Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res 2013; 37: 213-222 [PMID: 23009062 DOI: 10.1111/ j.1530-0277.2012.01936.x]
47. Zhang LJ, Zheng WD, Chen YX, Huang YH, Chen ZX, Zhang SJ, Shi MN, Wang XZ. Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology 2007; 54: 2092-2098 [PMID: 18251166]
48. Chen YX, Huang YH, Zheng WD, Chen ZX, Zhang LJ, Wang XZ. Interleukin-10 gene modification attenuates hepatocyte activation of rat hepatic stellate cells in vitro. Mol Med Rep 2013; 7: 371-378 [PMID: 23232951 DOI: 10.3892/ mmr.2012.1228]
49. Hsu HY, Chu LC, Hua KF, Chao LK. Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPS-stimulated human monocytes. J Cell Physiol 2008; 215: 603-612 [PMID: 18357586 DOI: 10.1002/jcp.21206]
50. Huang YC, Liu KC, Chiou YL, Yang CH, Chen TH, Li TT, Liu LL. Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway. Chem Biol Interact 2013; 205: 157-164 [PMID: 23872139 DOI: 10.1016/j.cbi.2013.07.008]